LONDON – Researchers have worked out how a normal brain protein can reduce levels of the harmful proteins that accumulate during the development of Alzheimer’s disease. The protein, called SORLA, is known to decrease concentrations of amyloid-beta peptides, which build up in Alzheimer’s disease.